Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Losmapimod in Healthy Japanese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 262, doi. 10.1002/cpdd.190
- By:
- Publication type:
- Article
Works matching IS 2160763X AND DT 2015 AND VI 4 AND IP 4
Results: 10
1
2
Clinical Pharmacology in Drug Development -- An Update.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 243, doi. 10.1002/cpdd.211
- By:
- Publication type:
- Article
3
Pharmacokinetics and Adhesion of a Transdermal Patch Containing Ethinyl Estradiol and Gestodene Under Conditions of Heat, Humidity, and Exercise: A Single-Center, Open-Label, Randomized, Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 245, doi. 10.1002/cpdd.185
- By:
- Publication type:
- Article
4
Population Pharmacokinetic/ Pharmacodynamic Assessment of Pharmacological Effect of a Selective Estrogen Receptor β Agonist on Total Testosterone in Healthy Men.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 305, doi. 10.1002/cpdd.184
- By:
- Publication type:
- Article
5
Absolute Oral Bioavailability and Pharmacokinetics of Canagliflozin: A Microdose Study in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 295, doi. 10.1002/cpdd.162
- By:
- Publication type:
- Article
6
Effect of Food on the Bioavailability and Tolerability of the JAK2-Selective Inhibitor Fedratinib (SAR302503): Results From Two Phase I Studies in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 315, doi. 10.1002/cpdd.161
- By:
- Publication type:
- Article
7
Relative Bioavailability of Pediatric Oral Solution and Tablet Formulations of Trametinib in Adult Patients With Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 287, doi. 10.1002/cpdd.152
- By:
- Publication type:
- Article
8
Effect of Food on the Pharmacokinetics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, and Assessment of Dose Proportionality in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 279, doi. 10.1002/cpdd.151
- By:
- Publication type:
- Article
9
An Open-Label Study to Determine the Pharmacokinetics and Safety of Migalastat HCl in Subjects With Impaired Renal Function and Healthy Subjects With Normal Renal Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 256, doi. 10.1002/cpdd.149
- By:
- Publication type:
- Article
10
Pharmacokinetic Profile After Multiple Deltoid or Gluteal Intramuscular Injections of Paliperidone Palmitate in Patients With Schizophrenia.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 270, doi. 10.1002/cpdd.144
- By:
- Publication type:
- Article